Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07220876 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
A NA study of Open Angle Glaucoma (OAG), sponsored by Avisi Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 165
- Enrollment target
- 12
- Study locations
NCT07220876: Recruiting NA study of Open Angle Glaucoma (OAG), sponsored by Avisi Technologies.
NCT07220876 is a NA study of Open Angle Glaucoma (OAG) that is actively recruiting participants, run by Avisi Technologies. The registered enrollment target is 165 participants, above the 35-participant average among 5 other Open Angle Glaucoma (OAG) trials with a reported enrollment target (371% higher). The trial reports 12 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07220876, a NA study of Open Angle Glaucoma (OAG), is actively recruiting participants, sponsored by Avisi Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 165 participants
- Enrollment target
- 12
- Study locations
Study Summary
A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial
Primary Outcome
The eye is filled with a special fluid. The intraocular pressure is the amount of fluid that builds up in the eye. The primary outcome is the number of people whose eye pressure went down by at least 20%.
Conditions Studied
Interventions
- DEVICE VisiPlate Glaucoma Implant
Study Locations (12)
Colorado
- ICON Eye Care - Grand Junction
- Mile High Eye Institute - Sheridan
Pennsylvania
- Scheie Eye Institute - Philadelphia
- Wills Eye Hospital - Philadelphia
Texas
- Glaucoma Associates of Texas - Dallas
- University of Texas Southwestern - Dallas
Other
- Lynette Venter - Bloemfontein
- Pretoria Eye Institute - Pretoria
Arizona
- Arizona Advanced Eye Research - Glendale
California
- Sacramento Eye Consultants - Sacramento
Ohio
- Cleveland Clinic- Cole Eye Institute - Cleveland
Wisconsin
- The Eye Centers of Racine & Kenosha - Kenosha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2025-11-07 |
| Est. Completion | 2027-10 |
| Phase | NA |
What NCT07220876 shows while recruiting
NCT07220876 is an interventional study that assigns participants to a tested intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, above the 35-participant average among 5 other Open Angle Glaucoma (OAG) trials with a reported enrollment target (371% higher).
The record links to 1 condition, with Open Angle Glaucoma (OAG) appearing as the primary indexed condition, and to 1 intervention - of which VisiPlate Glaucoma Implant is the first listed.
NCT07220876 lists 12 locations in 8 states (Colorado, Pennsylvania, Texas).
Frequently Asked Questions
What is clinical trial NCT07220876 about?
NCT07220876 is a clinical study titled "Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma". A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial
What is the current status of trial NCT07220876?
This trial is currently recruiting. It is a NA study. The enrollment target is 165 participants. The study started on 2025-11-07. Estimated completion is 2027-10.
What conditions does trial NCT07220876 study?
This clinical trial studies the following conditions: Open Angle Glaucoma (OAG).
What interventions are being tested in trial NCT07220876?
The interventions under investigation include: VisiPlate Glaucoma Implant (DEVICE).
Who is sponsoring clinical trial NCT07220876?
This trial is sponsored by Avisi Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07220876 being conducted?
This trial has 12 study locations across Arizona, California, Colorado, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Open Angle Glaucoma (OAG)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma
RECRUITING
-
Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
RECRUITING
-
Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
RECRUITING · Phase 1
-
Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation
RECRUITING · Phase 2
-
Travoprost Five Day Posology Study
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT03830320 · 165 participants · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
- NCT04289571 · 165 participants · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI